NSEScheme of Arrangement19 Jun 2026 · 19 Jun 2026, 10:21 am

Scheme of Arrangement

Apollo Hospitals Enterprise Limited · APOLLOHOSP

✦ AI Summary

Apollo Hospitals Enterprise Limited has announced a proposed composite scheme of arrangement involving itself and three other entities: Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. This restructuring initiative falls under Sections 230 to 232 of the Companies Act, 2013. While the initial announcement does not disclose specific financial figures or the full details of the scheme, it signals a significant corporate restructuring. Investors should monitor for further disclosures, as such arrangements can impact the company's business segments, asset allocation, and future valuations.

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement

Attachments (1)

📄

APOLLOHOSP_19062026102054_SE_Communc_19062026.pdf

pdf

Download →
View document text
,("0110 APOLLO HOSPITALS ENTERPRISE LIMITED 19' 2026CIN: l?osPITALS Date: June L85110TN1979PLC008035 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No. C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 508869 Bandra (E) ISIN INE437A01024 Mumbai - 400 051. Scrip Code - APOLLOHOSP !SIN INE437A01024 Dear Sir/ Ma'am, Sub: Proposed composite scheme of arrangement amongst Apollo Hospitals Enterprise Limited ("Company"), Apollo Healthco Limited {"Transferor Company 1"), Keimed Private Limited {"Transferor Company 2") and Apollo Healthtech Limited ("Resultant Company") and their respective shareholders and creditors ("Scheme",) under Sections 230 to 232, and other applicable provisions of the Companies Act, 2013 read with the rules made thereunder. Ref: Additional Information in relation to the Scheme. Pursuant to Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our communication dated June 15, 2026, please find enclosed a communication being issued by the Company providing additional information and clarifications in relation to the proposed Scheme involving Apollo Hospitals Enterprise Limited and Apollo Healthtech Limited. The communication sets out certain additional details and clarifications relating to governance matters under the Scheme, including the promoter and promoter group's commitments with respect to nomination rights, proposed amendments to the articles of association of Apollo Healthtech Limited, and matters pertaining to the composition of the board of directors of Apollo Healthtech Limited. The above information is also being made available on the Company's website. Kindly take the same on record. Thanking you, .M. K&TSHNAf\l Sr. VICE PRESIDEN:-f - FINANCE IS/ISO 9ocftNRJooOMPANY SECRETARY Regd. Office: General Office : Tel : 044 - 28290956 / 3896 / 6681 19, Bishop Gardens, "Ali Towers" Ill Floor, Telefax : 044 - 2829 0956 Raja Annamalaipuram, #55, Greams Road, Email : investor.relations@apollohospitals.com Chennai - 600 028. Chennai - 600 006. Website : www.apollohospitals.com ,(~0110 APOLLO HOSPITALS ENTERPRISE LIMITED l?osPITALS CIN: L85110TN1979PLC008035 Additional Information in relation to the Scheme Apollo Hospitals Enterprise Limited ("Apollo Hospitals" or the "Company") remains attentive to feed back received from shareholders and other stakeholders in relation to the proposed Composite Scheme of Arrangement ("Scheme"). The Company continues to believe that the Scheme represents an important step in unlocking value for shareholders by enabling the separation and independent listing of Apollo Healthtech Limited ("Apollo Healthtech"). The Board and management of Apollo Hospitals are of the view that the Scheme will provide Apollo Healthtech with a sharper strategic focus, greater operational flexibility, enhanced capital allocation ability and clearer visibility for investors into its performance and growth potential. On 15 June 2026, Apollo Hospitals clarified that Rasmeli Limited ("Rasmeli"), as well as the promoter and promoter group of Apollo Healthtech, are committed to waiving their respective rights to nominate director(s) when the respective shareholding of Rasmeli, or of the promoter and promoter group, as the case may be, falls below 10%. The Articles of Association of Apollo Healthtech will be suitably amended, after the Scheme becomes effective, to incorporate this fall-away threshold. Apollo Hospitals now further clarifies that the promoter and promoter group are committed to waiving their rights to nominate directors in excess of the maximum numbers set out below, by reference to their aggregate shareholding. Aggregate Shareholding of Promoter Maximum Number of Nominee and Promoter Group Directors Below 10% Nil 10% to below 15% Up to 2 directors 15% to below 25% Up to 3 directors 25% to below 35% Up to 4 directors 35% and above Up to 5 directors Within this framework provided above and the 10% fall-away threshold as already communicated, each constituent of the promoter and promoter group is additionally committed to waiving its right to nominate a director if its individual shareholding (together with entities controlled by it) falls below 5%. The Articles of Association of Apollo Healthtech will be suitably amended, after the Scheme becomes effective, to give effect to these waivers. Apollo Healthtech will seek a separate approval from its shareholders (after effectiveness of the Scheme) for the proposed amendment of the Articles. IS/ISO 9001 : 2000 Regd. Office : General Office : Tel 19, Bishop Gardens. "Ali Towers" Ill Floor, Telefax Raja Annamalaipuram, #55, Greams Road, Chennai - 600 028. Chennai - 600 006. .... ,(~0110 APOLLO HOSPITALS ENTERPRISE LIMITED l?osPITALS CIN : L8511 OTN 1979PLC008035 Further, so long as there is an executive chairperson, Apollo Healthtech will ensure that at least half of its Board will be constituted of independent directors, in accordance with applicable law. Conclusion Apollo Hospitals remains committed to upholding the trust of its shareholders and stakeholders through responsible governance, transparency and long-term value creation. The Scheme is an important step in this journey, positioning Apollo Healthtech for its next phase of growth with greater focus, independence and accountability. The Board believes the Scheme is in the best interests of all shareholders and respectfully seeks your support. Place : Chennai Date : June 19, 2026 IS/ISO 9001 : 2000 Regd. Office : General Office : Tel : 044 - 28290956 / 3896 / 6681 19, Bishop Gardens, "Ali Towers" Ill Floor, Telefax : 044 - 2829 0956 Raja Annamalaipuram, #55, Greams Road, Email : investor.relations@apollohospitals.com Chennai - 600 028. Chennai - 600 006. Website : www.apollohospitals.com